NASDAQ:CORT

Corcept Therapeutics Stock News

etoro logo Buy CORT
*Your capital is at risk
$72.65
+1.45 (+2.04%)
At Close: Jun 03, 2026

5 Growth ETFs & Stocks Set to Flourish in Spring

03:05pm, Wednesday, 15'th Apr 2020
Given the recovering sentiments, investors should reposition their portfolio for more exposure to the growth space to obtain a nice momentum play.

RedHill (RDHL) Soars: Stock Adds 9.2% in Session

12:44pm, Wednesday, 15'th Apr 2020
RedHill (RDHL) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.

RedHill (RDHL) Soars: Stock Adds 9.2% in Session

12:44pm, Wednesday, 15'th Apr 2020
RedHill (RDHL) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Corcept Therapeutics...
As of late, it has definitely been a great time to be an investor in Corcept Therapeutics.
As of late, it has definitely been a great time to be an investor in Corcept Therapeutics.
Alliancebernstein L.P. decreased its holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT) by 2.7% in the fourth quarter, according to the company in its most recent filing with the Securities a
Goldman Sachs Group Inc. boosted its holdings in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) by 64.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The f
Bank of New York Mellon Corp lowered its stake in Corcept Therapeutics Incorporated (NASDAQ:CORT) by 1.1% during the 4th quarter, according to the company in its most recent disclosure with the Securi
Janus Henderson Group PLC raised its position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) by 6.0% during the fourth quarter, according to its most recent disclosure with the Securitie
Mason Street Advisors LLC increased its stake in Corcept Therapeutics Incorporated (NASDAQ:CORT) by 3.1% in the 4th quarter, Holdings Channel reports. The fund owned 35,824 shares of the biotechnology
Cubist Systematic Strategies LLC raised its holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT) by 3.9% in the fourth quarter, according to the company in its most recent filing with the Secur
Credit Suisse AG reduced its position in Corcept Therapeutics Incorporated (NASDAQ:CORT) by 11.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (S
The big shareholder groups in Corcept Therapeutics Incorporated (NASDAQ:CORT) have power over the company. Insiders...
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE